Percutaneous left atrial appendage (LAA) occlusion is now a valid alternative to longterm oral anticoagulation in patients with non-valvular atrial fibrillation at high thromboembolism risk, especially for patients who are considered ineligible for anticoagulation. The most frequently used occluders worldwide include the WATCHAMN (Boston Scientific, Natick, MA, USA) and the Amplatzer Cardiac Plug or Amulet (St. Jude Medical/Abbott, St Paul, MN, USA) devices. Multimodality imaging is key in the understanding of 3D aspects of the LAA and surrounding structures anatomy. Imaging is essential for procedural planning, during each step of the procedure and for device surveillance after implantation. Multimodality imaging, including 2D/3D echocardiography, fluoroscopy, and cardiac computed tomography can increase the safety and efficacy of the procedure.
INTRODUCTION
Left atrial appendage (LAA) occlusion is increasingly recognized as a valid non-pharmacologic therapy for stroke prevention in high-risk patients with non-valvular atrial fibrillation (AF), especially in cases where long-term oral anticoagulation (OAC) therapy is contraindicated. Two randomized-controlled trials, the PROTECT AF and PRE-VAIL studies, have shown the safety and efficacy of this procedure in patients randomized to either LAA closure with the WATCHMAN device (Boston Scientific, Natick, MA, USA) or warfarin therapy [1, 2] . Two large registries in patients who were mostly contra-indicated or deemed unsuitable to long-term anticoagulation and treated with the Amplatzer Cardiac Plug (ACP) (St. Jude Medical/Abbott, St Paul, MN, USA) (ACP multicenter registry) [3] or the WATCHMAN (Ewolution registry) [4] have confirmed safety and efficacy of this procedure in this population. Currently, the European Society of Cardiology (ESC) guidelines for the management of AF recommend that LAA closure may be considered in patients with high-risk of stroke and contraindications to long-term OAC (class IIb, level of evidence B) [5] . The 2014 American (ACC/AHA/HRS) guidelines on management of AF have not made any recommendation on this procedure [6] . Food Drug Administration approval in the USA for the WATCHMAN device was obtained in March 2015 for patients with non-valvular AF and high-risk of stroke who have an appropriate rationale to seek a non-pharmacologic alternative to warfarin. Imaging is a key part of LAA occlusion as it portends patient selection, device selection, procedural guidance and post-implantation surveillance. Different imaging modalities are currently used for each of these steps, as multimodality imaging in this procedure has the potential to improve procedure safety and efficacy. Close collaboration and excellent communication between the operator and the imaging specialist are essential. The implanting team has to understand the various steps of the procedure, its complexity and 3D anatomy of the LAA and surrounding structures. This review will focus on the role of imaging in LAA closure with the most commonly used devices, the WATCHMAN and the ACP/Amulet. After explaining the role of imaging in the different steps of the procedure, specific aspects will be developed with emphasis on transoesophageal echocardiography (TOE) and cardiac computed tomography angiography (CCTA).
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High quality figures are available as online supplements.
Characteristics of the ACP/Amulet and Watchman Devices
The ACP or Amulet (second generation ACP) devices are self-expanding nitinol devices made of a distal lobe, designed to anchor the device in the LAA, connected by a short mobile waist to a proximal disc, covered by polyester patches and intended to seal the LAA orifice [7] . ACP sizing depends on the widest landing zone. It is recommended to oversize the device by 2-4 mm for the ACP and 3-6 mm for the Amulet from the widest measured landing zone. The WATCHMAN device is a self-expanding nitinol frame structure with fixation barbs and a permeable polyester fabric cover [8] . WATCHMAN sizing is based on the maximum LAA diameter, which should be 17 to 31 mm to accommodate available devices. A 8-20% compression ratio based on the widest measurement is recommended by the manufacturer, while most implanters will aim for the higher compression range (close to 20%). Given that the WATCH-MAN is almost as long as it is wide, the depth of the distal (implant) lobe has to be as deep as the diameter of the device chosen.
ROLe Of IMAgINg IN PROCeDUraL STePS

Pre-Procedural Planning
Baseline assessment of the LAA days to weeks prior to the procedure is a recommended standard of practice for percutaneous LAA occlusion. This evaluation will gather information about presence of thrombus, LAA morphology and size, other cardiac structures and will exclude contra-indications for LAA closure. TOE is the preferred modality but alternative (in case of contraindications to TOE) or complementary imaging by CCTA is increasingly performed [9, 10] . Many authors judge the presence of thrombus as an absolute contra-indication for LAA closure. If thrombus is detected during the pre-procedural work-up, anticoagulation should be initiated or intensified for at least 3-4 weeks with repeated imaging to confirm thrombus resolution before proceeding with LAA occlusion [6] . LAA morphology and dimensions can be identified in the pre-procedural study. The orifice diameter, the landing zone diameter and the depth of the LAA can be measured. This will orient device selection and ensure that LAA closure is feasible. Step-by-step 2D/3D Transoesophageal (TOE) Guidance for Left atrial Appendage (LAA) Occlusion with an Amulet Device. A:
Step 1: The transseptal needle is pulled down with imaging guidance in the bicaval view (from superior to inferior positioning). B:
Step 2: Bicaval and short-axis views allowing visualization of the needle tenting on the fossa ovalis. The goal is to puncture in the infero-posterior region of the fosa ovalis. The use of X-plane or Bi-plane view is recommended. C:
Step 3: Gentle advancement of the guide through the interatrial septum (IAS) is tracked in X-plane or Bi-plane view. D:
Step 4: The pigtail catheter is advanced inside the LAA. Real-time 3D TOE with zoom is the preferred modality for guidance. E:
Step 5: Positioning and deployment of the device lobe inside the LAA is followed on 3D TOE. F:
Step 6: Real-time 3D TOE with zoom shows the deployment of the disc at the level of the LAA orifice. The saddling of the disc in the LAA orifice can be imaged with 3D zoom mode. G:
Step 7: Position of the device lobe inside the LAA in relationship with the left circumflex (LCx) artery is assessed. 60 to 90⁰ views on 2D will image the LCx artery. H: Step 8: A tug test is performed to test device stability inside the LAA. I and J:
Step 9: Once the final position is considered appropriate, residual peri-device leaks are looked for with 2D color flow mode with adapted velocities at 45⁰, 60⁰, 90⁰ and 135⁰. Bi-plane views with color-flow can also be used (panel J). K:
Step 10: On 3D zoom, the anatomic relationship between the disc of the device, the left pulmonary veins and the mitral valve are evaluated. L:
Step 12: Color flow Doppler of the left pulmonary veins is performed together with pulsed-wave Doppler to exclude any compression on the pulmonary veins by the device.
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The orientation of the LAA may help operators in selecting the type of access sheath. Characteristics of the inter-atrial septum (IAS) will be assessed as some features may be associated with a difficult transseptal puncture (TSP). For instance, the presence of thick or aneurysmal IAS will be evaluated.
Procedural guidance
Interventions are performed with fluoroscopy while TOE allows guidance during the different procedural steps (Fi 1). TOE guidance during TSP is an important step as a puncture in the optimal infero-posterior region of the fossa ovalis may greatly facilitate further steps of LAA occlusion. Live TOE guidance improves safety of the TSP and increases the likelihood of an optimal TSP location. Wire and pigtail catheter position can also be identified more easily with TOE and procedure time may be shortened with guidance. Sheath positioning is visualized with TOE and fluoroscopy, ensuring a good co-axial alignment and access to the culprit (or implant) lobe. LAA morphology and sizing will be estimated by both imaging in several incidences. It is important to ensure that adequate filling pressure is present within the LA cavity to avoid underestimation of the dimension of the LAA landing zone [11] . Successful implantation is evaluated based on pre-specified criteria; different for each device and ensuring complete seal and good stability. The presence of complications is best assessed by TOE (e.g., pericardial effusion, mitral valve impingement, left pulmonary vein occlusion).
Post-Procedural Device Surveillance
We routinely perform Chest X-ray and transthoracic echocardiography (TTE) before patient discharge to ensure the absence of device embolization and pericardial effusion. Post-procedural TOE and/or CCTA can be performed 1-3 months post-implantation. Imaging will assess presence of device-associated thrombus (DAT) and peri-device leaks and will rule out any complication (e.g., device embolization, pericardial effusion). Results of post-implantation imaging are used in many centers to modify antithrombotic treatment (switch form warfarin to dual antiplatelet therapy (DAPT) or from DAPT to aspirin alone). Further imaging is indicated in case of clinical events potentially related to device complication (Table 1) .
ROLe Of IMAgINg IN SPeCIfIC SITUATIONS OR INDICATIONS
Sizing
Correct sizing is of utmost importance for the optimization of the efficacy and safety of the procedure. Proper sizing will allow complete closure of the LAA with good device stability. Undersizing may increase peri-device leakage and increases the risk of device instability leading to dislodgement and embolization. Oversizing increases the risk of pericardial effusion, cardiac perforation and cardiac tamponade, long-term erosion and device instability. Thus, precise knowledge of LAA orifice dimensions is crucial for the selection of the occluder size. The measurements should be performed when the LAA size is the largest, at the end of the ventricular systole and under normal LA filling conditions. Performing multiple measurements in different views and ideally with multiple imaging modalities is necessary in order to select the proper device type and appropriate device size for LAA closure. Depending on the device used, specific measurements will be performed. The short-axis view enables measurements of maximal LAA diameters while the long-axis view allows measurement of the LAA depth. With the probe in mid-oesophageal position, TOE imaging planes from 0-135° are obtained to perform measurements. 3D TOE may also be useful to find maximal and mean diameters. On CCTA, 3D multiplanar reconstruction (MPR) is typically used. Given the orientation of LAA, standard orthogonal views are indeed inadequate. 2D oblique measurements are used after manipulation of cross-sectional orthogonal views. After identification of the LAA orifice in a plane showing the circumflex artery and the pulmonary vein ridge, an orthogonal plane is obtained to ensure good co-axial alignment. The orthogonal "end-on" view allows measurements of LAA dimensions at selected area of interest (Fi 2). 
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High quality figures are available as online supplements. Perimeter-derived diameter is the most reproducible parameter for sizing an LAA occluder. It provides mean and maximum diameters of the landing zone and may improve correct device selection, resulting in less over-or undersizing [12] [13] [14] . For the ACP/Amulet, the size of the device is mostly based on the landing zone diameter, where the lobe will be anchored. The "anatomical" ostium is the plane that joins the left superior pulmonary vein rim (the ligament of Marshall) superiorly with the inferior junction of LA/LAA at the level of the left circumflex artery. The landing zone can be found 10 mm (for ACP) and 12 mm (for Amulet) below this segment, perpendicular to the major axis of the LAA, usually at the junction between the neck and the body of the LAA. The depth of the appendage is measured from the landing zone to the most distal tip of the main lobe of the appendage (Fig 3) . For the WATCHMAN device, the LAA anatomical orifice diameter is measured on TOE at 0°, 45°, 90° and 135°. The "effective" LAA orifice is defined as the plane connecting the pulmonary vein ridge superiorly (1-2cm within the left upper superior pulmonary vein ridge) to the inferior junction of the LA and the LAA at the level of the circumflex artery. The widest dimension should be used for sizing. Maximal length or depth of LAA is defined as the linear distance from the center of the landing zone to the distal tip of the main lobe of the appendage (Fig 4) . figure 3: TOE evaluation of a patient before left atrial appendage (LAA) closure by the Amulet device. Images are acquired in the mid-oesophageal view focused on the LAA at 0⁰, at 45⁰ at 90⁰ and at 125-135⁰. Measurements are performed in a frame that gives the largest LAA, usually in end-systole. The orifice of the LAA is measured in each of these views. The landing zone (the part of the LAA in which the lobe of the Amulet device will be fixed) is measured in each of these views at 10-12 mm from the LAA orifice. The depth is measured in the main lobe of the LAA. The shape of the LAA ostium is typically elliptical; other shapes have been less frequently described [13, 15] . Markedly oval-shaped orifices or landing zones are associated with a significant difference between maximal and minimal diameters, which can be confounding and may lead to overor under-sizing. Manufacturers' recommendations for sizing are based on maximal diameter on TOE. The elliptical shape of LAA short-axis has led to the development of more flexible devices (last generation devices), allowing for more successful occlusion. The LAA usable depth is measured in the long-axis view from the LAA orifice to the LAA apex. On TOE, the angle of choice depends on LAA orientation. Angles of 0°, 45° or 90° are typically used. In case of more
laterally orientated LAA, angle of 90° or more are necessary. On CCTA, the depth is best assessed on 3D MPR. The required depth is different between devices: ACP/Amulet devices need 10-12 mm to accommodate the lobe, WATCH-MAN requires an equivalent depth as the diameter of the device. In a study by Saw et al., fluoroscopy, 2D TOE and CCTA showed good correlations for LAA measurements. CT provided the largest measurements, followed by TOE and fluoroscopy [16] . In another study, LAA dimensions measured by CCTA correlated with the diameters obtained with fluoroscopy and intracardiac echocardiography (ICE), but they were slightly larger than the others [17] . A particular value of CCTA may be the detection and subsequent avoidance of gross sizing error by 2D TOE that occurred in a small proportion of cases (3.4%) in a single-center registry [18] . In most studies, CCTA most often predicts the appropriate device size [10, 17, 19] . The use of real time 3D TOE for the visualization and quantitative analysis of LAA parameters is more frequent and has several advantages. RT3D-TEE allows better spatial visualisation of the LAA and more comprehensive evaluation of the device and surrounding structures during the procedure. The use of MPR mode in 3D TOE allows correct identification and direct planimetric measurement of the LAA orifice area (Fig 5) . The measurements correlate well with those obtained with cardiac CT and are associated with a lower observer variability and higher accuracy and reliability than 2D TOE. Indeed, 2D TOE tends to significantly underestimate the maximal LAA orifice diameter compared to 3D TOE. There is a closer correlation between 3D TOE measurements and LAA closure device size than 2D TOE or angiographic measurements. After implantation, the device can be visualized more completely with 3D TOE [14, [20] [21] [22] [23] . LAA is thought to have several functions, including acting as a reservoir during left ventricular systole. As such, LAA volume and sizes may vary with pressure and volume loading conditions. Typically, a minimal left atrial pressure of 10-15 mmHg is mandatory before final device sizing assessment. Intraprocedural volume loading with saline, aiming for a LA pressure >12 mmHg, showed an increase in LAA dimensions in a small study [11] .
Morphology and Orientation
The morphology of the LAA is extremely complex and heterogeneous. Individual LAA morphology is unique and may sometimes be referred to as a fingerprint. In more than two-thirds of the cases, LAA is composed of 2 or more lobes that may be located in different planes [24] . Early TOE anatomical studies described numerous shapes of LAA: narrow, tubular and hooked structure [25] . Currently used classification of LAA morphology is based on the general shape of the LAA. The four classical shapes are windsock (single dominant lobe without obvious bend), chicken wing (obvious bend in the body of the LAA), cactus (dominant central lobe with multiple secondary lobes) and cauliflower (short body with numerous secondary lobes and more complex internal characteristics) [13] . Different studies have evaluated a correlation between the thromboembolism risk and LAA morphological or structural features. LAA morphology has been shown to be a significant determinant of LAA flow Step-by-step Real-time 3D TOE Evaluation for Left Atrial Appendage (LAA) Closure Device Sizing.
Step 1: In the frame with the largest LAA dimensions (usually end-systole), the first plane is positioned to transect the left circumflex (LCx) artery (this plane cuts the LAA showing the inferior and the superior walls of the LAA) and aligned to be parallel to the long-axis of the LAA.
Step 2: The second orthogonal plane is aligned with the long-axis of the LAA (Panel A).
Step 3: The third plane, the axial plane (green), is moved to be at the intersection of the LCx artery and the ridge of the left upper pulmonary vein. At this point the diameters of the LAA orifice can be measured (Panel B).
Step 4: The axial plane (green) is moved into the LAA to the estimated landing zone. The diameters of the landing zone can be measured in this view. (Panel C). For the WATCHMAN, this plane should transect the LCx artery and a point lower than the ridge but above the trabeculated parts of the LAA. For the Amulet-ACP, this plane is moved 10-12 mm into the LAA from the LAA ostium. In our example, the measurements were made before Amulet implantation. The area-derived and perimeter-derived diameters were respectively 18.5 and 19.1cm 2 .
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velocity, suggesting an underlying mechanism for the association between LAA morphology and embolic events [26] . Patients with chicken wing LAA morphology were shown to less likely develop an embolic event even after controlling for comorbidities and CHADS 2 score [27] . This was confirmed in a recent meta-analysis [28] . Large LAA neck diameter and LAA depth as well as extensive LAA trabeculations may also be predictors of thromboembolic events [29] . Accurate assessment of the anatomic LAA characteristics is crucial before an LAA occlusion procedure as variations in LAA anatomy may impact device selection and procedure strategy. Understanding LAA morphology can help anticipating the complexity of the procedure and the need for the use of some unusual techniques. For example, the presence of a chicken wing morphology with an early and severe bend constitutes one of the most difficult anatomical settings for LAA occlusion. A particular implanting strategy has been described with the ACP-Amulet device and consists of deploying the distal lobe of the device inside the chicken-wing bend ('Sandwich' technique) [30] . However, in some very complex chicken wing configuration or in case of very shallow LAA, the anatomy may be judged as inappropriate for LAA closure. Determination of LAA orientation also has procedural implications. Most LAA are orientated superior-anteriorly. For this reason, most LAA occlusion procedures are performed with the so called double-curve sheaths (double-curve access sheath for WATCHMAN, Boston Scientific; TV45x45 for ACP/ Amulet, Saint-Jude Medical/Abbott). In cases of LAA oriented infero-posteriorly, a single-curve may be preferred [13] . Images obtained by volume rendered (VR) 3D CCTA can also be useful to plan the procedure. With manipulation of VR images, it is possible to determine the best corresponding fluoroscopic views to guide LAA occlusion during the procedure. The choice of the fluoroscopic views during the procedure relies on the LAA anatomy and on the device selected for the occlusion. The right anterior oblique (RAO) view with cranial projection (RAO 20-30°, cranial 20-30°) identifies the left lateral ridge and shows the orifice and proximal segment of the LAA best, which is particularly useful for ACP/Amulet implantation. On TOE, this view corresponds usually to the 45° view. The RAO view with caudal projection (RAO 20-30°, Caudal 20-30°), corresponding to the 135° view on TOE, can separate the possible anterior and posterior lobes and shows the body and distal segment of the LAA, which is useful for sheath placement in the distal lobe and for WATCHMAN deployment. As in transcatheter aortic valve implantation, CCTA can help planning the precise fluoroscopic implant angle.
Transseptal Puncture
Transseptal puncture is performed under fluoroscopy. Left anterior oblique view (30°) is preferred as the transseptal needle is located perpendicular to the septum in this view when oriented at about 45° medially and posteriorly (clockwise, 4-6 o'clock orientation). After a first drop from the superior vena cava to the right atrium (RA) wall, the second drop confirms needle position in the fossa ovalis. TOE is useful for the transseptal puncture guidance as it allows targeting the infero-posterior region of the septum to perform the puncture ( Figure 6 ). Simultaneous TOE images demonstrate tenting of the inter-atrial septum (IAS) due to pressure from the needle prior to the puncture. In the upper oesophageal position, the bicaval view (90-110°) assesses the height of the puncture, while the short-axis view (30-60°) gives information about the antero-posterior position and allows puncture to be away from the aorta. As mentioned, ideal puncture location lies in the infero-posterior region of the IAS as it facilitates coaxial orientation of the access sheath for accessing the LAA. TOE can identify features that may be associated with complex transseptal puncture (thick IAS, very enlarged LA, aneurysmal IAS) and can therefore change procedural strategy (use of radiofrequency transseptal needle, increased transseptal needle curve…).
Successful Implantation
After implantation, evaluation of the success of the implantation and the absence of complications are of utmost importance. TOE remains the gold-standard imaging modality for assessing the success of the implantation but fluoroscopy is complimentary. For the WATCHMAN, the PASS criterion should be achieved: Position (device is distal to or at the ostium of the LAA), Anchor (device is stable, fixation anchors engaged, tug test stability), Size (device is compressed 8-20% of original size), Seal (device spans ostium, all lobes of LAA are covered, peri-device leak <5mm). For the ACP/Amulet device, 5 criteria are used to
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High quality figures are available as online supplements. assess implantation adequacy: (1) tire-shape of the lobe, (2) separation of the lobe from the disc, 3) concavity of the disc, (4) axis of the lobe is perpendicular to the neck axis at landing zone, (5) lobe (at least 2 thirds) lies adequately within the circumflex artery. The disc should cover completely the anatomical orifice of the LAA. Gentle traction is applied to the disc and maintained for 30 seconds to confirm stability. The absence of significant peri-device leaks is assessed by TOE in all incidences (by color flow Doppler with Nyquist limit < 50cm.s -1 ) (Fig 7, panel A) . CCTA can also detect peri-device leaks and identify the underlying mechanism. Different aetiologies explain peri-device leaks. In WATCHMAN cases, leaks are mostly eccentric and secondary to an edge effect. For ACP/Amulet cases, higher proportion of off-axis lobes were found in cases of patent LAA [31, 32] and leaks were more frequent when lobe compression was ≤ 10% [33] . In the presence of peri-device leak ≥5mm, resuming or pursuing antithrombotic therapy or further intervention may be considered. However, the clinical impact of peri-device leak is unknown with no clear relationship with adverse events [3, 4, 34] .
Thrombus
The rationale for LAA closure development was that around 90% of thrombi in the LA originated in the LAA in patients with non-valvular AF after evaluation by autopsy, TOE or operation [35] . In AF patients, LAA structure and function have several characteristics that make LAA a prothrombotic milieu favouring thrombus formation. The elements of the Virchow's triad are found in this setting: blood stasis in this blind-ended pouch with trabeculations and electromechanical dysfunction [36, 37] , endothelial dysfunction (secondary to fibrosis and inflammation) [38] . and prothrombotic state (linked to the activation of coagulation cascade) [39, 40] . The presence of thrombus is usually considered as an absolute contra-indication for LAA closure, even though several cases of LAA occlusion with Amulet have been described [41, 42] . The standard of best practice recommends anticoagulation treatment for at least 3-4 weeks in case of detection of thrombus in the LAA [6] . Control imaging after this period to confirm thrombus resolution is recommended before procedure planning. Left atrial (LA) thrombus on TOE is recognized as an echo dense mass, with smooth contours and synchronous movement with adjacent heart wall during heart cycle. TOE is considered the gold standard modality in detecting LA or LAA thrombi. In one intraoperative study, TOE was compared with direct visualization of LA contents at surgery and had a sensitivity and specificity of 100% and 99%, respectively [43] 3D TOE can help discriminate pectinate muscles from thrombus in cases with diagnostics doubts [44] . In case of uncertainty about the presence of a thrombus in the LAA, the use of ultrasound contrast can be helpful [45] . Studies with mutlidetector CT have reported good sensitivity and specificity for CCTA for LAA thrombus detection [46, 47] . Recent meta-analysis demonstrated that CT shows a good diagnostic accuracy in detecting LA/ LAA thrombus with high sensitivity and specificity [48, 49] . This technique has a high negative predictive value for excluding LAA thrombus. Adaptation to CCTA protocols may improve LAA thrombus detection: delayed imaging (2-phase scan with delayed image acquisition at least 30 seconds after contrast bolus), dual-enhanced scan (single scan after 2-bolus contrast), dual-energy source and prone position [50, 51] . When delayed imaging was performed, the diagnostic accuracy significantly improved across different studies [49] . Hence, CCTA, particularly when delayed imaging is performed, may be a reliable alternative for the detection of LA or LAA thrombi. Thrombus appears in this setting as round-shaped or oval filling defects (Fig 7, panel B) .
The presence of DAT is assessed during post-procedural device surveillance. DAT is not rare, with an overall reported rate of 3.9% in a recent review [52] . Diagnosis is most of the time performed during routine follow-up imaging, as most cases remain asymptomatic. Management consist mostly on short-term anticoagulation. Recently, Main et al. have proposed consensus echocardiographic diagnostic criteria for DAT diagnosis: echo density on the LA aspect of the device (1) not explained by imaging artefact; (2) inconsistency with normal healing/device incorporation; (3) visible in multiple TOE planes, (4) in contact with the LAA occluder device; and (5) exhibiting independent motion [53] . CCTA is also able to detect DAT or thrombus on the adjacent LA wall [32] .
Complications
Device embolization is a well-known and feared complication of LAA closure with an average reported rate of less than 4% [54] , and less than 1% in recent registries [3, 4] . In a systematic review by Aminian et al., two-thirds of reported cases were acute, with 60% of those cases occurring during the procedure. Most cases were asymptomatic [55] . Device embolization may be diagnosed by fluoroscopy, chest X-ray, TTE, TOE or CCTA (Fig 7, panel C) . Pericardial effusion incidence is decreasing with last generation of devices, standardization and better understanding of the procedure [2] . Pericardial effusion occurs mostly
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during the procedure and is best diagnosed by echocardiography. Pericardiocentesis is rarely necessary and can be echo-guided.
ALTeRNATIVe AND fUTURe IMAgINg MO DALITIeS Intracardiac echocardiography (ICe)
With a successful ICE-guided LAA closure reported rate ≥ 97%, ICE has proved to be a valid alternative imaging modality for LAA occlusion in experienced centers [56] [57] [58] [59] . The main advantage of ICE utilization is that it avoids the need for general anaesthesia or deep sedation, which can be associated with additional complications (aspiration, delirium…), lead to longer procedure-time and to additional resource utilization. Of note, a recent small study showed the feasibility of LAA closure using conscious sedation with TOE guidance [60] whereas another study described the use of an ICE-TOE probe through the oesophageal route without general anaesthesia for the monitoring of ACP device implantation [61] . ICE currently lacks multiplanar capabilities and may provide suboptimal imaging of LAA, even though the ability to move the probe in different positions may compensate these shortcomings. Furthermore, location of the ICE probe within the LA cavity improves imaging of the LAA. The main disadvantages of ICE remain the additional cost and a significant learning curve. Several ICE catheters are commercially available including the AcuNav ultrasound catheter (Siemens Medical Solutions, USA, Inc., Mountain View, CA, USA) and the ViewFlex Xtra catheter (St. Jude Medical/Abbott). Both systems are available in 8-10 Fr size and can be steered in 4 directions (anterior, posterior, left, and right). They also have color flow and spectral Doppler capabilities. The catheters are inserted from the ipsilateral or contralateral femoral vein via large venous sheaths and advanced from the inferior vena cava to the working position. The ICE probe can be positioned in the RA, the coronary sinus [56] , the pulmonary artery [62] or the LA via a single-transseptal approach or after a second transseptal puncture [57] . Once the desired position is achieved, the probe can be set in that position with a lock mechanism. ICE can provide detailed imaging of the LAA in multiple views with serial and real-time assessment of the procedures steps (Fig 8) . ICE guidance is able to achieve tasks typically performed by TOE: evaluation of the presence of thrombus [63] ; transseptal puncture guidance [64] measurement of LAA dimension for device sizing [17] ; verification of the delivery sheath position; evaluation of device stability and peri-device leaks and continuous monitoring to detect procedural complications [56] .
Integrated/Synchronized X-Ray and echocardiography (fusion Imaging)
LAA occlusion procedures under fluoroscopic and echocardiographic guidance with image fusion technology have been described with good results [65] . The EchoNavigator ®-system (Philips, Best, The Netherlands) is based on a fast and automated image based algorithm that localizes and tracks the TOE probe. Since the 3D dataset generated by the TOE probe has a known spatial relationship to the TOE probe, once the algorithm has recognized the TOE probe and its orientation, TOE images and X-Ray are co-registered and synchronized in real-time (Fig 9) [66]. 
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The system allows the simultaneous display of up to 3 different echo views: 1) the C-arm gantry view, in which the echo view is oriented in the same anatomic alignment as the x-ray view and automatically updated by each movement of the C-arm gantry; this image is then fused with the X-ray view and both images are concordant in size and orientation; 2) the « echo » view, which is the standard TOE projection showing up on the echo machine; and 3) a free image that can be rotated or cropped by the operator at the table site by using a sterile mouse pad. This view allows the operator to manipulate the real-time images without the need to request further TOE projections. There is also a marker feature that allows setting markers on anatomical location of interest on the echo image that are automatically displayed on the X-Ray image. This imaging modality seems useful for the transseptal puncture and for sheath and device positioning. This technology has the potential to improve the interaction between the operator and the imager. Whether this imaging modality may increase safety, accuracy, and efficacy of LAA occlusion has yet to be demonstrated. Of note, a preliminary study showed a significant reduction in radiation dose and fluoroscopy time with the use of the EchoNavigator®-system [67] . 
Rotational Angiography
Rotational angiography (3DRA) is an innovative method that allows per-procedural reconstruction of tomographic slices of a volume of interest in a manner similar to CT, using singe plane radiographic equipment [68, 69] . These slices can be used to perform measurements in any plane of the 3D volume, or to make a 3D reconstruction of a structure of interest and integrate it with fluoroscopy or other 3D mapping technologies. In the setting of LAA closure, the technology can be leveraged to create near-real time 3D models of the LAA. These models provide anatomical guidance by overlaying the model on the live 2D fluoroscopy image. Using tools typically provided by the manufacturer of the X-Ray equipment, the 3D model can be appropriately sized and positioned on the 2D image, and rotates automatically with the angle of the imaging tube to provide the correct visualization (Fig 1) . In addition, a multiplanar reconstruction can be made through any arbitrary angle, such that a planar slice can be created at the base of the appendage perpendicular to the long-axis of the appendage in that position. This slice can be used to measure the exact dimensions of the base of the LAA without imaging imperfections that may be present with TOE in certain anatomies (Fig 2 or Fig 3 or both) . Preliminary data suggest this workflow may offer more accurate selection of the most appropriate LAA occluder size (unpublished data).
CONCLUSIONS
Imaging has a key role in every step of LAA occlusion: pre-procedural planning, procedural guidance and post-implantation surveillance. Several imaging modalities are available and offer complementary information, allowing good understanding of the LAA anatomy and its relationship to the surrounding structures. Multimodality imaging should be used to improve procedural safety and efficacy of LAA occlusion.
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